Moderna Shares Soar After Personalized mRNA Cancer Vaccine Succeeds in Phase III Trial
Moderna and Merck reported the first successful Phase III trial of a personalized mRNA cancer vaccine, sending Moderna shares sharply higher.
This page serves as the chronological archive of all MarketSpeaker content, organizing published material by date rather than topic or format. It aggregates news, briefs, guides, and other editorial outputs into a time-based structure, allowing readers to track coverage across specific periods. Designed for researchers, analysts, and returning readers, the archive provides a clear historical view of market narratives and reporting cycles. Unlike category or tag pages, it emphasizes temporal navigation over thematic grouping.
Moderna and Merck reported the first successful Phase III trial of a personalized mRNA cancer vaccine, sending Moderna shares sharply higher.
Unitree Robotics shares surged more than 500% on their Shanghai trading debut, briefly valuing the humanoid robot maker at around $50 billion.
Anthropic is reportedly considering issuing supervoting shares to its founders ahead of its expected IPO, helping preserve their control as the AI company prepares to go public.
QuantumLight, the venture capital firm founded by Revolut CEO Nik Storonsky, has raised $500 million for its second fund, doubling the size of its debut vehicle.
Anthropic generated more quarterly revenue than OpenAI for the first time, while OpenAI paused a major AI model training run over growing cybersecurity concerns.
Citi will launch its Custody+ platform later this year, allowing institutional clients to hold Bitcoin alongside traditional assets within a single custody framework.
The U.S. national debt is now expected to reach $40 trillion months earlier than previously forecast, while investors demand higher yields to finance rising government borrowing.
Pre-IPO futures tied to Unitree Robotics have surged more than 300% above the company’s IPO valuation, implying a market value of roughly $40.5 billion ahead of its Shanghai debut.
AI chip startup Groq has raised $350 million at a $3.5 billion valuation, nearly half its previous $6.9 billion peak after Nvidia licensed its technology and hired away key executives.
Anthropic’s annualized revenue has reportedly surpassed $65 billion ahead of its expected IPO, as investors increasingly focus on the company’s long-term growth projections.